Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

LINK-001

Source date not recordedAnalyse record ↗

Preclinical anti-necrotic candidate intended to inhibit acute tubular necrosis in kidney disease as an initial aging-related indication.

Modality
anti-necrotic drug candidate
Availability (US)
Preclinical studies complete; no clinical trial reported
Biomarkers
necrotic cell death; acute tubular necrosis; kidney-injury measures
Hallmark targeted
altered intercellular communication, chronic inflammation, cell death
Kind
investigational drug